Opentrons Labworks, Inc. is a leader in lab automation and makers of accessible lab robotics. The company accelerates innovation in research and healthcare through its integrated lab platform, including business units Opentrons Robotics and Neochromosome. Opentrons has raised over $200 million in funding and achieved unicorn status based on its first- and second-generation robots, OT-One and OT-2. The recently launched Opentrons Flex is Opentrons’ next generation of liquid-handling lab robots, offering open-source accessibility and compatibility with generative AI tools.